Payments to Acquire Property, Plant, and Equipment of Verve Therapeutics, Inc. from 31 Dec 2019 to 31 Mar 2025

Taxonomy & unit
us-gaap: USD
Description
The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.
Summary
Verve Therapeutics, Inc. quarterly and annual Payments to Acquire Property, Plant, and Equipment in USD history and change rate from 31 Dec 2019 to 31 Mar 2025.
  • Verve Therapeutics, Inc. Payments to Acquire Property, Plant, and Equipment for the quarter ending 31 Mar 2025 was $1,224,000, a 183% increase year-over-year.
  • Verve Therapeutics, Inc. annual Payments to Acquire Property, Plant, and Equipment for 2024 was $3,736,000, a 60% decline from 2023.
  • Verve Therapeutics, Inc. annual Payments to Acquire Property, Plant, and Equipment for 2023 was $9,283,000, a 30% decline from 2022.
  • Verve Therapeutics, Inc. annual Payments to Acquire Property, Plant, and Equipment for 2022 was $13,232,000, a 204% increase from 2021.
Source SEC data
View on sec.gov
Payments to Acquire Property, Plant, and Equipment, Quarterly (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Quarterly Change (%)
Payments to Acquire Property, Plant, and Equipment, Annual (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Annual Change (%)

Verve Therapeutics, Inc. Quarterly Payments to Acquire Property, Plant, and Equipment (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $1,224,000 +$791,000 +183% 01 Jan 2025 31 Mar 2025 10-Q 14 May 2025 2025 Q1
Q1 2024 $433,000 -$2,942,000 -87% 01 Jan 2024 31 Mar 2024 10-Q 14 May 2025 2025 Q1
Q1 2023 $3,375,000 +$467,000 +16% 01 Jan 2023 31 Mar 2023 10-Q 08 May 2024 2024 Q1
Q1 2022 $2,908,000 +$1,838,000 +172% 01 Jan 2022 31 Mar 2022 10-Q 15 May 2023 2023 Q1
Q1 2021 $1,070,000 01 Jan 2021 31 Mar 2021 10-Q 10 May 2022 2022 Q1

Verve Therapeutics, Inc. Annual Payments to Acquire Property, Plant, and Equipment (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $3,736,000 -$5,547,000 -60% 01 Jan 2024 31 Dec 2024 10-K 27 Feb 2025 2024 FY
2023 $9,283,000 -$3,949,000 -30% 01 Jan 2023 31 Dec 2023 10-K 27 Feb 2025 2024 FY
2022 $13,232,000 +$8,873,000 +204% 01 Jan 2022 31 Dec 2022 10-K 27 Feb 2025 2024 FY
2021 $4,359,000 +$935,000 +27% 01 Jan 2021 31 Dec 2021 10-K 27 Feb 2024 2023 FY
2020 $3,424,000 +$1,567,000 +84% 01 Jan 2020 31 Dec 2020 10-K 02 Mar 2023 2022 FY
2019 $1,857,000 01 Jan 2019 31 Dec 2019 10-K 14 Mar 2022 2021 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.